The GLP Journal
Medications
Drug-by-drug profiles: semaglutide, tirzepatide, liraglutide, and the next generation.
Semaglutide: Dosing, Side Effects, and Real-World Data
The molecule behind Wegovy and compounded semaglutide — mechanism, dosing, and what the trials show.
10 min read · Updated 2026-09-14
Tirzepatide: The Dual Receptor Agonist Explained
How tirzepatide targets both GIP and GLP-1 receptors, and what the SURMOUNT trials found.
10 min read · Updated 2026-09-13
Liraglutide: The First-Generation GLP-1
The original GLP-1 receptor agonist — daily dosing, the SCALE trials, and where it fits today.
8 min read · Updated 2026-09-11
Retatrutide: The Triple Agonist in Development
The triple agonist targeting GLP-1, GIP, and glucagon — what the TRIUMPH Phase 3 trials showed.
9 min read · Updated 2026-09-10